Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 40,000 shares at $90.44 ($3.6M) on 2020-11-02, disclosed to the SEC on 2020-11-04.
Open-market sale of $3.6M EBS by Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.44 | 20,000 | $1.8M | 49.9% |
| 2 | $90.74 | 20,000 | $1.8M | 50.1% |
| Total | $90.59 avg | 40,000 | $3.6M | 100% |
| Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |
| EBS | SELL | 2020-05-01 | $3.0M | — | Filing → |